1. Arcadia Biosciences Announces CFO Transition

    — Pam Haley to be replaced by Thomas J. Schaefer effective January 3, 2023 — DAVIS, Calif. (November 30, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CFO Pam Haley will be leaving the company and will be replaced by Thomas J. Schaefer,…Continue Reading »
  2. Arcadia Biosciences Announces Strong Third Quarter 2022 Financial Results and Business Highlights

    — GoodWheat™ Pasta distribution doubles from Q2 — Gross margins improve to 28% — Streamlined operations focus on higher-margin brands  DAVIS, Calif. (November 10, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022….Continue Reading »
  3. Arcadia Biosciences Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (October 27, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022. The company has scheduled a…Continue Reading »
  4. Arcadia Biosciences to Participate in Upcoming Investor Conferences

    DAVIS, Calif. (August 31, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and Pam Haley, CFO, will be participating in two investor conferences during the month of September. H.C. Wainwright 24th Annual Global Investment Conference. Arcadia will…Continue Reading »
  5. Arcadia Biosciences Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif. (August 16, 2022) — Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced the closing of its previously announced registered direct offering of 4,722,506 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.05876 per share, priced…Continue Reading »
  6. Arcadia Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market

    DAVIS, Calif. (August 12, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock (or common stock equivalents) at…Continue Reading »
  7. Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights

    — Revenue increased 175% from Q2 2021 — GoodWheat™ pasta successfully launched in retail and online — $2M milestone achievement recognized for HB4® soybean approval in China DAVIS, Calif. (August 11, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results…Continue Reading »
  8. Arcadia Biosciences Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (July 28, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022. The company has scheduled a conference…Continue Reading »